Ajanta Pharma has informed that the Company is expanding its manufacturing capabilities by adding a state-of-the-art liquid formulation facility at its Pithampur site. This enhancement is aimed at meeting the growing global demand for the Company's liquid formulations. The details, as required pursuant to Regulation 30 (4) (c) of the Listing Regulations, are enclosed. The above information is also being uploaded on the website of the Company at https://www.ajantapharma.com/.
The above information is a part of company’s filings submitted to BSE.
